DNAprint Genomics (DNAG)

[worktoplay]

froggy...How do you know that there will be "no money changing hands here."

Might I refer you to the DNAPrint website under Products/Pharmacogenomics:

FDA rules regarding pharmacogenomics testing are still evolving and we are seeking additional guidance from the FDA on this issue. Until OVANOMETM is FDA approved or deemed to not require FDA approval, we plan on generating revenues through physician guided Investigative New Drug studies.

Physician guided new drug studies...isn't that a large part of what they will be doing at Moffit? Aren't we working with the Associate Center Director for Clinical Investigations?

IMO, though not assured, there is a distinct possibility that some revenue would be generated during the course of this work.

Later,
W2P